Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice

Vaccine

Volumn 19, Issue 30, 2001, Pages 4219-4225

  Zheng, Bo Jian ^a   Ng, Mun Hon ^a   He, Li Fang ^b   Yao, Xin ^b   Chan, Kwok Wah ^a   Yuen, Kwok Yung ^a   Wen, Yu Mei ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Immune tolerance; Therapeutic vaccine

Indexed keywords

GAMMA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B SURFACE ANTIGEN ANTIBODY COMPLEX; HEPATITIS B SURFACE ANTIGEN RECOMBINANT DNA ANTIBODY; HEPATITIS B VACCINE; PLASMID DNA; RECOMBINANT HEPATITIS B SURFACE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENETIC CODE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNOMODULATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TRANSGENIC MOUSE; VIRUS GENE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CYTOKINES; DNA, RECOMBINANT; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035919599     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00158-X     Document Type: Article

References (17)

1. Specific vaccine therapy in chronic hepatitis B infection
2. Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: "A possible way of circumventing nonresponse" to HBsAg
3. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection
4. Solid matrix-antibody-antigen complex can clear viremia and antigenemia in persistent duck hepatitis B virus infection
5. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens
6. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans
7. Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection
8. Effect of plasmid DNA on immunogenicity of HbsAg-anti-HB5 complex
9. DNA based immunization for hepatitis B induces continuous secretion of antigens and high level of circulating antibody
10. + cytotoxic T lymphocyte responses in vivo
11. A new microcellular cytotoxic test based on calcein AM release
12. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity
13. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
14. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state
15. Viral clearance without destruction of infected cells during acute HBV infection
16. Antigen-antibody complex as therapeutic vaccine for viral hepatitis B
17. Lymphocyte activation by CpG dinucleotide motifs in prokaryotic DNA